The U.S. Food and Drug Administration approved a record number of drugs in 2014, approving 41 first-of-a-kind drugs and a record number of medicines for rare diseases.
Expected to be released this year, the new PCAB (Pharmacy Compounding Accreditation Board) Certification Program for Canadian Compounding will provide compounding pharmacies with an independent, third-party review of their practice.